Therapeutic agent for amyotrophic lateral sclerosis (ALS)
US6933310B1 · kind B1 · utility
7Cited by
3References
5Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 13, 2000 |
| Grant date | Aug 23, 2005 |
| Priority date | — |
| Expiry date | Nov 13, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D231/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An object of the present invention is to provide a novel medicament with which motor neuron diseases can be treated. According to the present invention, there is provided a therapeutic agent for motor neuron diseases which comprises 3-methyl-1-phenyl-2-pirazoline-5-on or physiologically acceptable salts thereof as an active ingredient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.